Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial

Research output: Contribution to journalJournal articleResearchpeer-review

6 Citations (Scopus)
Original languageEnglish
JournalThe Lancet Diabetes and Endocrinology
Volume8
Issue number5
Pages (from-to)407-417
Number of pages11
ISSN2213-8587
DOIs
Publication statusPublished - May 2020

Fingerprint Dive into the research topics of 'Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial'. Together they form a unique fingerprint.

Cite this